Despite significant efforts, the cellular compartment that gives rise to pancreatic ductal adenocarcinoma (PDAC), one of the most lethal human cancers, remains obscure. In this issue of Cancer Cell, Gidekel Friedlander and colleagues demonstrate that under conditions of tissue damage, mutant Kras can drive previously unsuspected insulin-positive endocrine cells into PDA
Background & aimsActivating mutation of the KRAS gene is common in some cancers, such as pancrea...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers with a dismal 7% 5-year survi...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Despite significant efforts, the cellular compartment that gives rise to pancreatic ductal adenocarc...
SummaryPancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. To inve...
Pancreatic ductal adenocarcinoma (PDA) is a devastating malignancy with limited and modest clinical ...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. To investigate...
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis and lacks a human cell model of e...
SummaryPancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. To inve...
SummaryPancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis and lacks a human cell mod...
Cancer can be conceptualized as arising from somatic mutations resulting in a single renegade cell e...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a low survival rate. This is no...
Activating mutations in KRAS are the hallmark genetic alterations in pancreatic ductal adenocarcinom...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers with a dismal 7% 5-year survi...
Background & aimsActivating mutation of the KRAS gene is common in some cancers, such as pancrea...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers with a dismal 7% 5-year survi...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Despite significant efforts, the cellular compartment that gives rise to pancreatic ductal adenocarc...
SummaryPancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. To inve...
Pancreatic ductal adenocarcinoma (PDA) is a devastating malignancy with limited and modest clinical ...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. To investigate...
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis and lacks a human cell model of e...
SummaryPancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. To inve...
SummaryPancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis and lacks a human cell mod...
Cancer can be conceptualized as arising from somatic mutations resulting in a single renegade cell e...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a low survival rate. This is no...
Activating mutations in KRAS are the hallmark genetic alterations in pancreatic ductal adenocarcinom...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers with a dismal 7% 5-year survi...
Background & aimsActivating mutation of the KRAS gene is common in some cancers, such as pancrea...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers with a dismal 7% 5-year survi...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...